December has historically been a favorable month for the stock market. Investors often talk about the Santa Claus rally, a pattern where equities show strength during the final stretch of the year. Whether that rally materializes or not, dividend investors have an advantage. High quality income stocks can pay off regardless of short-term market mood.

Below are three dividend names that stand out for December. All offer reliable income, strong business fundamentals, and clear visibility into future cash flow. For investors looking for stability heading into 2026, these companies deserve a closer look.

AbbVie: A Dividend King With Durable Growth Drivers

AbbVie’s dividend yield now sits slightly above 3 percent, lower than levels investors saw a few years ago. That decline is actually a sign of strength. The company has not cut its dividend. In fact, AbbVie has increased its payout for 53 straight years, placing it firmly among the Dividend Kings.

The yield looks smaller today because AbbVie’s stock price has climbed sharply this year. Even after that run, the valuation remains reasonable. Shares trade at a forward price to earnings ratio near 16.8, below the S&P 500 healthcare sector’s average of 18.7.

The biggest story for AbbVie is how successfully it engineered a transition away from Humira, once the top selling drug in the world. The loss of U.S. exclusivity in 2023 was expected to be a major hit. Instead, AbbVie’s next generation autoimmune treatments, Rinvoq and Skyrizi, have rapidly filled the gap. Combined revenue for the two drugs grew more than 40 percent year over year in the most recent quarter, underscoring strong physician adoption and expanded market share.

AbbVie also continues to invest aggressively in research and strategic acquisitions, bolstering its immunology, oncology, and neuroscience pipelines. Investors who prefer companies with proven management and consistent execution may find AbbVie appealing.

Ares Capital: A High Yield Giant in a Growing Market

Ares Capital has not delivered standout performance so far this year, but the long-term story remains compelling. Since its IPO in 2004, the business development company has generated total returns more than 40 percent higher than the S&P 500. Income investors gravitate toward Ares for a simple reason. The stock currently yields more than 9 percent, and the company has maintained or raised its dividend for 16 straight years.

Ares benefits from the expansion of private credit and direct lending. Large banks have retrenched, leaving non-bank lenders with a huge and expanding opportunity set. The company estimates its total addressable market at roughly 5.4 trillion dollars across both middle market borrowers and larger enterprises with more than 1 billion dollars in annual revenue.

The nearer term outlook appears healthier than earlier in the year. Management highlighted this momentum on its latest earnings call. CEO Kort Schnabel said Ares “saw a noticeable acceleration in the volume of transactions under review, both sequentially and compared to the prior year, with more deals reviewed in September than in any month this year.”

If interest rates drift lower in 2026, Ares could see improving deal flow, healthier refinancing activity, and stronger credit performance. For income focused portfolios, Ares remains one of the more established and conservative players in the BDC universe.

Enbridge: Reliable Income and a Growing Role in North American Energy

Enbridge stands out as one of the most dependable dividend stocks in the energy sector. The company currently offers a yield of about 5.8 percent and has raised its dividend for 30 consecutive years. That combination of income stability and long-term payout growth is increasingly rare among large energy companies.

Shares have also posted a double-digit percentage gain this year, supported by a resilient business model. Enbridge operates one of the largest energy infrastructure networks in North America, and now also the continent’s largest natural gas utility. Around 80 percent of its EBITDA is insulated from inflation and commodity price swings, a key point for risk-conscious investors.

Growth is not slowing, either. The rapid expansion of artificial intelligence and cloud computing is fueling record demand for electricity, which in turn is increasing demand for natural gas. More utilities continue to transition from coal to natural gas, and Enbridge is positioned at the center of that shift. The company sees as much as 50 billion dollars in potential growth projects through 2030, nearly half tied directly to its gas transmission network.

For investors who want steady cash generation with room for expansion, Enbridge checks multiple boxes.

Reliability and Future Upside

December is often a strong month for markets, but dividend investors do not need seasonal tailwinds to win. AbbVie provides defensive healthcare exposure backed by a robust pipeline. Ares Capital offers one of the highest sustainable yields in the market with a long track record of outperformance. Enbridge brings stability, predictable cash flow, and multiyear growth opportunities linked to North America’s natural gas demand.

As always, investors should consider valuation, risk tolerance, and diversification before making any moves. But for those seeking quality income opportunities to close out the year, these three companies offer a compelling mix of reliability and future upside.